Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06687161 · ClinicalTrials.gov registry record · NA
Treating Insomnia in Mild Cognitive Impairment
A NA study of Insomnia and Mild Cognitive Impairment (MCI), sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06687161: Recruiting NA study of Insomnia and Mild Cognitive Impairment (MCI), sponsored by Beth Israel Deaconess Medical Center.
NCT06687161 is a NA study of Insomnia and Mild Cognitive Impairment (MCI) that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 30 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06687161, a NA study of Insomnia and Mild Cognitive Impairment (MCI), is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to test a new way to improve sleep quality in persons living with mild cognitive impairment. The treatment combines a safe and gentle way to stimulate the brain, called transcranial magnetic stimulation, with a psychological treatment, called cognitive behavioral therapy for insomnia.
Primary Outcome
The Insomnia Severity Index (ISI) is a brief self-assessment tool used to measure the severity of insomnia. It consists of seven questions that evaluate sleep problems, their impact on daily life, and the individual's level of concern about their sleep issues. The total score helps to categorize the severity of insomnia from mild to severe.
Conditions Studied
Interventions
- DEVICE Transcranial Magnetic Stimulation (TMS) therapy
- BEHAVIORAL Cognitive behavioral therapy for insomnia (CBT-I)
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT06687161 shows while recruiting
NCT06687161 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (82% lower).
The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Magnetic Stimulation (TMS) therapy is the first listed.
NCT06687161 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06687161 about?
NCT06687161 is a clinical study titled "Treating Insomnia in Mild Cognitive Impairment". The goal of this study is to test a new way to improve sleep quality in persons living with mild cognitive impairment. The treatment combines a safe and gentle way to stimulate the brain, called transcranial magnetic stimulation, with a psychological treatment, called cognitive behavioral therapy fo...
What is the current status of trial NCT06687161?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-05-01. Estimated completion is 2028-06-30.
What conditions does trial NCT06687161 study?
This clinical trial studies the following conditions: Insomnia, Mild Cognitive Impairment (MCI).
What interventions are being tested in trial NCT06687161?
The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) therapy (DEVICE), Cognitive behavioral therapy for insomnia (CBT-I) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06687161?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06687161 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06687161's enrollment target sits among peer trials
30 122nd of 151 higher than 25 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI